SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-046278
Filing Date
2019-02-21
Accepted
2019-02-21 09:00:32
Documents
2
Period of Report
2019-02-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d674516d8k.htm 8-K 24256
2 EX-7.1 d674516dex71.htm EX-7.1 1944
  Complete submission text file 0001193125-19-046278.txt   27402
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38533 | Film No.: 19620629
SIC: 2834 Pharmaceutical Preparations